PDCD1 and colorectal carcinoma: To investigate whether, and to what extent, the disturbed gut microbiota from CRC patients have contributed to the resistance to anti-PD-1 mAb treatment in clinic, the feces from five newly diagnosed CRC patients and five healthy controls were collected in our institute.